(Q45749690)

15 December 2017

title

Immunoreconstitution after ritonavir therapy in children with human immunodeficiency virus infection involves multiple lymphocyte lineages (English)

1 reference

15 December 2017

1 reference

Sleasman JW

1

1 reference

15 December 2017

Nelson RP

2

1 reference

15 December 2017

Goodenow MM

3

1 reference

15 December 2017

Wilfret D

4

1 reference

15 December 2017

Hutson A

5

1 reference

15 December 2017

Baseler M

6

1 reference

15 December 2017

Zuckerman J

7

1 reference

15 December 2017

Pizzo PA

8

1 reference

15 December 2017

Mueller BU

9

1 reference

15 December 2017

language of work or name

English

0 references

publication date

1 May 1999

1 reference

15 December 2017

The Journal of Pediatrics

published in

1 reference

15 December 2017

volume

134

1 reference

15 December 2017

issue

5

1 reference

15 December 2017

page(s)

597-606

1 reference

15 December 2017

Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970247-7

A preliminary study of ritonavir, an inhibitor of HIV-1 protease, to treat HIV-1 infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970247-7

Alterations in the immune response of human immunodeficiency virus (HIV)-infected subjects treated with an HIV-specific protease inhibitor, ritonavir

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970247-7

A phase I/II study of the protease inhibitor ritonavir in children with human immunodeficiency virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970247-7

Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970247-7

Apoptosis occurs predominantly in bystander cells and not in productively infected cells of HIV- and SIV-infected lymph nodes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970247-7

HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970247-7

Kinetics of response in lymphoid tissues to antiretroviral therapy of HIV-1 infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970247-7

Decay characteristics of HIV-1-infected compartments during combination therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970247-7

Age, thymopoiesis, and CD4+ T-lymphocyte regeneration after intensive chemotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970247-7

Thymic involution with ageing: obsolescence or good housekeeping?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970247-7

T cell activation in pediatric AIDS pathogenesis: three-color immunophenotyping

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970247-7

Isoforms of the CD45 common leukocyte antigen family: markers for human T-cell differentiation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970247-7

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970247-7

Early Progression of Disease in HIV-Infected Infants with Thymus Dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970247-7

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970247-7

Subpopulations of T and B cells in perinatally HIV-infected and noninfected age-matched children compared with those in adults.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970247-7

Viral load and disease progression in infants infected with human immunodeficiency virus type 1. Women and Infants Transmission Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970247-7

Importance of age at infection with HIV-1 for survival and development of AIDS in UK haemophilia population. UK Haemophilia Centre Directors' Organisation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970247-7

Prognosis in HIV-1 infection predicted by the quantity of virus in plasma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970247-7

A trial comparing nucleoside monotherapy with combination therapy in HIV-infected adults with CD4 cell counts from 200 to 500 per cubic millimeter. AIDS Clinical Trials Group Study 175 Study Team

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970247-7

Zidovudine, Didanosine, or Both as the Initial Treatment for Symptomatic HIV-Infected Children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970247-7

Lymphocyte subsets in healthy children during the first 5 years of life

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970247-7

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970247-7

Basic principles of ROC analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970247-7

CD95-induced apoptosis contributes to loss of primed/memory but not resting/naive T cells in children infected with human immunodeficiency virus type 1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970247-7

Immunologic responses associated with 12 weeks of combination antiretroviral therapy consisting of zidovudine, lamivudine, and ritonavir: results of AIDS Clinical Trials Group Protocol 315.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970247-7

Turnover of naive- and memory-phenotype T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970247-7

Lymphocyte recirculation and life span in vivo.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970247-7

Evolution of phenotypic memory T cells in HIV-1 infected infants and children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970247-7

CD4+ memory T cells are the predominant population of HIV-1-infected lymphocytes in neonates and children.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970247-7

Preferential infection of CD4+ memory T cells by human immunodeficiency virus type 1: evidence for a role in the selective T-cell functional defects observed in infected individuals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970247-7

Lymphocyte activation in HIV-1 infection. I. Predominant proliferative defects among CD45R0+ cells of the CD4 and CD8 lineages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970247-7

Human immunodeficiency virus drug therapy and virus load.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970247-7

inferred from DOI database lookup

7 January 2021

based on heuristic

Impaired fitness of human immunodeficiency virus type 1 variants with high-level resistance to protease inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970247-7

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0022-3476(99)70247-7

1 reference

15 December 2017

1 reference

15 December 2017